Rat Model for Myocardiosis

Cardiomyopathy

  • Product No.DSI596Ra02
  • Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
  • Prototype SpeciesHuman
  • SourceInduced by furazolidone
  • Model Animal StrainsWistar Rats(SPF), healthy, half male and half female, body weight 150g-180g.
  • Modeling GroupingRandomly divided into six group: Control group, Model group, Positive drug group and Test drug group(low,medium,high).
  • Modeling Period4-6 weeks
  • Modeling MethodUse 2weeks wistar rats, Feed furazolidone according to the dose of 2mg/g body weight. Adjust the dose once a week by body weight, total 10 weeks. Another normal control group is the simple breastfeeding and normal feed. Observations include: ①Electrocardiogram detection, record I, II, III, aVR, aVL, aVFsix lead ECG. ②Echocardiography, Using ultrasonic system with probe frequency of 7.5MHZ. ③Blood test. ④Pathological examination.
  • Applicationsn/a
  • Download n/a
  • UOM Each case
  • FOB US$
    For more details, please contact local distributors!
  • Rat Model for Myocardiosis Packages (Simulation)
  • Rat Model for Myocardiosis Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Model Evaluation of the Rat Model for Myocardiosis

Pathological Results of the Rat Model for Myocardiosis

Cytokines Level of the Rat Model for Myocardiosis

Statistical Analysis of the Rat Model for Myocardiosis

SPSS software is used for statistical analysis, measurement data to mean ± standard deviation (x ±ｓ), using t test and single factor analysis of variance for group comparison, P<0.05 indicates there was a significant difference, P<0.01 indicates there are very significant differences.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
DSI596Ra01 Rat Model for Myocardiosis n/a
DSI596Ra02 Rat Model for Myocardiosis n/a
GUESTBOOK